{"date":"2026-05-26","count":38,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-3218-2026-05-26-1835-acgheb","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"18:35:18","subject":"公告本公司預計於新台幣5億元額度內取得有價證券（補充115/05/12公告）","clause":"第20款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-26 18:35，「公告本公司預計於新台幣5億元額度內取得有價證券（補充115/05/12公告）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3218-2026-05-26-1827-6rqyk5","company_id":"3218","company":"大學光","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"18:27:36","subject":"公告本公司取得有價證券","clause":"第20款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：大學光（3218），2026-05-26 18:27，「公告本公司取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-05-26-1815-1sfxptu","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"18:15:06","subject":"公告本公司115年股東常會決議通過解除現任董事及其代表人競業行為之限制案","clause":"第21款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-05-26 18:15，「公告本公司115年股東常會決議通過解除現任董事及其代表人競業行為之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6844-2026-05-26-1814-1jb8ii5","company_id":"6844","company":"諾貝兒","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"18:14:52","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：諾貝兒（6844），2026-05-26 18:14，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6703-2026-05-26-1811-cobe39","company_id":"6703","company":"軒郁","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"18:11:21","subject":"公告本公司115年股東常會重要決議","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：軒郁（6703），2026-05-26 18:11，「公告本公司115年股東常會重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-05-26-1741-1inikyi","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"17:41:30","subject":"公告本公司115年配息基準日及相關事宜","clause":"第14款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-05-26 17:41，「公告本公司115年配息基準日及相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-5312-2026-05-26-1741-1jb8ii5","company_id":"5312","company":"寶島科","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"17:41:16","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：寶島科（5312），2026-05-26 17:41，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2026-05-26-1731-18f3uow","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"17:31:35","subject":"公告本公司114年度除息基準日更正","clause":"第14款","fact_date":"2026-05-25","cite_as":"公開資訊觀測站重大訊息：進階（3118），2026-05-26 17:31，「公告本公司114年度除息基準日更正」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4197-2026-05-26-1726-1w05ak6","company_id":"4197","company":"暐世","market":"興櫃","industry":"生技醫療","date":"2026-05-26","time":"17:26:05","subject":"公告本公司因會計師事務所內部輪調之需要更換會計師","clause":"第7款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：暐世（4197），2026-05-26 17:26，「公告本公司因會計師事務所內部輪調之需要更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4104-2026-05-26-1718-lrkgsj","company_id":"4104","company":"佳醫","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"17:18:18","subject":"公告本公司受統一證券邀請舉辦公開法人說明會","clause":"第12款","fact_date":"2026-05-27","cite_as":"公開資訊觀測站重大訊息：佳醫（4104），2026-05-26 17:18，「公告本公司受統一證券邀請舉辦公開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-05-26-1644-11a2puo","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"16:44:36","subject":"代重要子公司創益生技股份有限公司公告股東會決議通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-05-26 16:44，「代重要子公司創益生技股份有限公司公告股東會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-05-26-1642-czp76c","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"16:42:30","subject":"代重要子公司創益生技股份有限公司公告除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-05-26 16:42，「代重要子公司創益生技股份有限公司公告除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2026-05-26-1641-lw65it","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"16:41:40","subject":"代重要子公司創益生技股份有限公司公告115年股東常會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2026-05-26 16:41，「代重要子公司創益生技股份有限公司公告115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6535-2026-05-26-1623-1v24kg5","company_id":"6535","company":"順藥","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"16:23:52","subject":"公告本公司LT3001治療急性缺血性腦中風之新成份新藥，多劑量給藥之作用機轉探索性臨床試驗，通過台灣衛生福利部食品藥物管理署審核。","clause":"第10款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：順藥（6535），2026-05-26 16:23，「公告本公司LT3001治療急性缺血性腦中風之新成份新藥，多劑量給藥之作用機轉探索性臨床試驗，通過台灣衛生福利部食品藥物管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-05-26-1618-x910b9","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"16:18:20","subject":"本公司對世紀民生科技股份有限公司及星雲電腦股份有限公司公開收購本公司普通股股份之相關事宜說明","clause":"第38款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-05-26 16:18，「本公司對世紀民生科技股份有限公司及星雲電腦股份有限公司公開收購本公司普通股股份之相關事宜說明」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4127-2026-05-26-1604-1dk4dl","company_id":"4127","company":"天良","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"16:04:59","subject":"本公司對世紀民生科技股份有限公司及星雲電腦股份有限公司公開收購本公司普通股股份之審議委員會結果","clause":"第38款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：天良（4127），2026-05-26 16:04，「本公司對世紀民生科技股份有限公司及星雲電腦股份有限公司公開收購本公司普通股股份之審議委員會結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6875-2026-05-26-1602-3il1nf","company_id":"6875","company":"國邑*","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"16:02:56","subject":"公告本公司115年度股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：國邑*（6875），2026-05-26 16:02，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3176-2026-05-26-1557-jflio5","company_id":"3176","company":"基亞","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"15:57:46","subject":"公告本公司115年股東會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：基亞（3176），2026-05-26 15:57，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6949-2026-05-26-1549-11uowq","company_id":"6949","company":"沛爾生醫*-創","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"15:49:22","subject":"本公司受邀參加台新證券舉辦之「台新2026年第二季全球投資論壇」","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：沛爾生醫*-創（6949），2026-05-26 15:49，「本公司受邀參加台新證券舉辦之「台新2026年第二季全球投資論壇」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4162-2026-05-26-1537-1jb8ii5","company_id":"4162","company":"智擎","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"15:37:11","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：智擎（4162），2026-05-26 15:37，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-05-26-1525-lshwdk","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"15:25:08","subject":"公告修正本公司115年議事手冊及股東會各項議案參考資料部份內容","clause":"第53款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-05-26 15:25，「公告修正本公司115年議事手冊及股東會各項議案參考資料部份內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-05-26-1522-1jb8ii5","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"15:22:02","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-05-26 15:22，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-05-26-1521-1uh66a","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"15:21:46","subject":"公告本公司董事長選任情形","clause":"第6款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-05-26 15:21，「公告本公司董事長選任情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2026-05-26-1521-zk0qd9","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"15:21:35","subject":"公告本公司115年股東常會重要決議事項。","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2026-05-26 15:21，「公告本公司115年股東常會重要決議事項。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-05-26-1521-xz10a9","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"15:21:28","subject":"公告本公司新任薪資報酬委員會委員","clause":"第6款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-05-26 15:21，「公告本公司新任薪資報酬委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-05-26-1520-tc88vo","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"15:20:13","subject":"公告本公司新任審計委員會委員","clause":"第6款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-05-26 15:20，「公告本公司新任審計委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-05-26-1519-1a6l1n","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"15:19:55","subject":"公告本公司115年股東常會決議通過解除新任董事及其代表人競業限制案","clause":"第21款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-05-26 15:19，「公告本公司115年股東常會決議通過解除新任董事及其代表人競業限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6782-2026-05-26-1519-7sf6el","company_id":"6782","company":"視陽","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"15:19:23","subject":"公告本公司115年股東常會全面改選董事(含獨立董事)","clause":"第6款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：視陽（6782），2026-05-26 15:19，「公告本公司115年股東常會全面改選董事(含獨立董事)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8403-2026-05-26-1450-1migin0","company_id":"8403","company":"盛弘","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"14:50:31","subject":"德信證券邀請本公司參加法人說明會","clause":"第12款","fact_date":"2026-05-27","cite_as":"公開資訊觀測站重大訊息：盛弘（8403），2026-05-26 14:50，「德信證券邀請本公司參加法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-05-26-1441-o7nqvu","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"14:41:53","subject":"代重要子公司台灣味群工業股份有限公司公告董事會通過董事長續任","clause":"第6款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-05-26 14:41，「代重要子公司台灣味群工業股份有限公司公告董事會通過董事長續任」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-05-26-1441-1sqtvcb","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"14:41:34","subject":"代重要子公司台灣味群工業股份有限公司公告股東會通過解除新任董事競業禁止之限制案","clause":"第21款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-05-26 14:41，「代重要子公司台灣味群工業股份有限公司公告股東會通過解除新任董事競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-05-26-1441-ok2eaw","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"14:41:18","subject":"代重要子公司台灣味群工業股份有限公司公告115年度股東會全面改選董事及監察人","clause":"第6款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-05-26 14:41，「代重要子公司台灣味群工業股份有限公司公告115年度股東會全面改選董事及監察人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4102-2026-05-26-1440-dztweb","company_id":"4102","company":"永日","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"14:40:53","subject":"代重要子公司台灣味群工業股份有限公司公告115年度股東會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：永日（4102），2026-05-26 14:40，「代重要子公司台灣味群工業股份有限公司公告115年度股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2026-05-26-1430-1jb8ii5","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"14:30:55","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2026-05-26 14:30，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-05-26-1422-jflio5","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"14:22:43","subject":"公告本公司115年股東會重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-05-26 14:22，「公告本公司115年股東會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2026-05-26-1415-3il1nf","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2026-05-26","time":"14:15:31","subject":"公告本公司115年度股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2026-05-26 14:15，「公告本公司115年度股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2026-05-26-1415-s1z5ib","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"14:15:29","subject":"公告本公司115年4月份自結合併財務報告之負債比率、流動比率及速動比率","clause":"第53款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2026-05-26 14:15，「公告本公司115年4月份自結合併財務報告之負債比率、流動比率及速動比率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6569-2026-05-26-1114-1jb8ii5","company_id":"6569","company":"醫揚","market":"上櫃","industry":"生技醫療","date":"2026-05-26","time":"11:14:31","subject":"公告本公司115年股東常會重要決議事項","clause":"第18款","fact_date":"2026-05-26","cite_as":"公開資訊觀測站重大訊息：醫揚（6569），2026-05-26 11:14，「公告本公司115年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}